Aspira Women's Health Inc.
AWHL
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 9.31M | 9.18M | 8.96M | 8.92M | 8.99M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 9.31M | 9.18M | 8.96M | 8.92M | 8.99M |
Cost of Revenue | 3.48M | 3.70M | 3.75M | 3.76M | 3.70M |
Gross Profit | 5.83M | 5.48M | 5.21M | 5.16M | 5.29M |
SG&A Expenses | 17.34M | 18.54M | 18.42M | 18.67M | 18.98M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 24.12M | 25.46M | 25.95M | 26.28M | 26.27M |
Operating Income | -14.81M | -16.28M | -16.98M | -17.35M | -17.28M |
Income Before Tax | -10.32M | -13.09M | -14.80M | -15.95M | -14.74M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -10.32 | -13.09 | -14.80 | -15.95 | -14.74 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -10.32M | -13.09M | -14.80M | -15.95M | -14.74M |
EBIT | -14.81M | -16.28M | -16.98M | -17.35M | -17.28M |
EBITDA | -14.73M | -16.19M | -16.87M | -17.22M | -17.12M |
EPS Basic | -0.68 | -0.99 | -1.20 | -1.45 | -1.44 |
Normalized Basic EPS | -0.50 | -0.69 | -0.79 | -0.94 | -1.01 |
EPS Diluted | -0.68 | -0.99 | -1.20 | -1.45 | -1.44 |
Normalized Diluted EPS | -0.50 | -0.69 | -0.79 | -0.94 | -1.01 |
Average Basic Shares Outstanding | 66.23M | 56.49M | 50.18M | 44.55M | 40.43M |
Average Diluted Shares Outstanding | 66.23M | 56.49M | 50.18M | 44.55M | 40.43M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |